204 related articles for article (PubMed ID: 27835898)
1. Prognostic significance of USP33 in advanced colorectal cancer patients: new insights into β-arrestin-dependent ERK signaling.
Liu H; Zhang Q; Li K; Gong Z; Liu Z; Xu Y; Swaney MH; Xiao K; Chen Y
Oncotarget; 2016 Dec; 7(49):81223-81240. PubMed ID: 27835898
[TBL] [Abstract][Full Text] [Related]
2. USP33 is a Biomarker of Disease Recurrence in Papillary Thyroid Carcinoma.
Jia M; Guo Y; Lu X
Cell Physiol Biochem; 2018; 45(5):2044-2053. PubMed ID: 29533940
[TBL] [Abstract][Full Text] [Related]
3. Reduced Expression of Deubiquitinase USP33 Is Associated with Tumor Progression and Poor Prognosis of Gastric Adenocarcinoma.
Chen Y; Pang X; Ji L; Sun Y; Ji Y
Med Sci Monit; 2018 May; 24():3496-3505. PubMed ID: 29802710
[TBL] [Abstract][Full Text] [Related]
4. SEMA3F prevents metastasis of colorectal cancer by PI3K-AKT-dependent down-regulation of the ASCL2-CXCR4 axis.
Zhou ZH; Rao J; Yang J; Wu F; Tan J; Xu SL; Ding Y; Zhan N; Hu XG; Cui YH; Zhang X; Dong W; Liu XD; Bian XW
J Pathol; 2015 Aug; 236(4):467-78. PubMed ID: 25866254
[TBL] [Abstract][Full Text] [Related]
5. Beta-arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2.
Shenoy SK; Modi AS; Shukla AK; Xiao K; Berthouze M; Ahn S; Wilkinson KD; Miller WE; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6650-5. PubMed ID: 19363159
[TBL] [Abstract][Full Text] [Related]
6. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
7. Reduced USP33 expression in gastric cancer decreases inhibitory effects of Slit2-Robo1 signalling on cell migration and EMT.
Xia Y; Wang L; Xu Z; Kong R; Wang F; Yin K; Xu J; Li B; He Z; Wang L; Xu H; Zhang D; Yang L; Wu JY; Xu Z
Cell Prolif; 2019 May; 52(3):e12606. PubMed ID: 30896071
[TBL] [Abstract][Full Text] [Related]
8. BACH1 promotes the progression of human colorectal cancer through BACH1/CXCR4 pathway.
Zhu GD; Liu F; OuYang S; Zhou R; Jiang FN; Zhang B; Liao WJ
Biochem Biophys Res Commun; 2018 May; 499(2):120-127. PubMed ID: 29481800
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of ANO9 in stage II and III colorectal carcinoma.
Li C; Cai S; Wang X; Jiang Z
Oncotarget; 2015 Oct; 6(30):29324-34. PubMed ID: 26317553
[TBL] [Abstract][Full Text] [Related]
10. USP33 regulates c-Met expression by deubiquitinating SP1 to facilitate metastasis in hepatocellular carcinoma.
Gan Q; Shao J; Cao Y; Lei J; Xie P; Ge J; Hu G
Life Sci; 2020 Nov; 261():118316. PubMed ID: 32835698
[TBL] [Abstract][Full Text] [Related]
11. USP33 mediates Slit-Robo signaling in inhibiting colorectal cancer cell migration.
Huang Z; Wen P; Kong R; Cheng H; Zhang B; Quan C; Bian Z; Chen M; Zhang Z; Chen X; Du X; Liu J; Zhu L; Fushimi K; Hua D; Wu JY
Int J Cancer; 2015 Apr; 136(8):1792-802. PubMed ID: 25242263
[TBL] [Abstract][Full Text] [Related]
12. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
13. Deubiquitinating enzyme USP33/VDU1 is required for Slit signaling in inhibiting breast cancer cell migration.
Yuasa-Kawada J; Kinoshita-Kawada M; Rao Y; Wu JY
Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14530-5. PubMed ID: 19706539
[TBL] [Abstract][Full Text] [Related]
14. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
[TBL] [Abstract][Full Text] [Related]
15. USP33, a new player in lung cancer, mediates Slit-Robo signaling.
Wen P; Kong R; Liu J; Zhu L; Chen X; Li X; Nie Y; Wu K; Wu JY
Protein Cell; 2014 Sep; 5(9):704-13. PubMed ID: 24981056
[TBL] [Abstract][Full Text] [Related]
16. CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases.
Yopp AC; Shia J; Butte JM; Allen PJ; Fong Y; Jarnagin WR; DeMatteo RP; D'Angelica MI
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S339-46. PubMed ID: 21584832
[TBL] [Abstract][Full Text] [Related]
17. A new strategy with a grading system for liver metastases from colorectal cancer.
Komeda K; Hayashi M; Inoue Y; Shimizu T; Asakuma M; Hirokawa F; Miyamoto Y; Uchiyama K
Hepatogastroenterology; 2015; 62(137):111-7. PubMed ID: 25911879
[TBL] [Abstract][Full Text] [Related]
18. UCH-LI acts as a novel prognostic biomarker in gastric cardiac adenocarcinoma.
Yang H; Zhang C; Fang S; Ou R; Li W; Xu Y
Int J Clin Exp Pathol; 2015; 8(11):13957-67. PubMed ID: 26823707
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of USP33 inhibits Slit/Robo signaling pathway and is associated with poor patient survival of glioma.
Han PP; Zhang GQ; Li L; Yue L
J Neurosurg Sci; 2023 Feb; 67(1):113-120. PubMed ID: 32972109
[TBL] [Abstract][Full Text] [Related]
20. Deubiquitinase USP33 is negatively regulated by β-TrCP through ubiquitin-dependent proteolysis.
Cheng Q; Yuan Y; Li L; Guo T; Miao Y; Ren Y; Liu J; Feng Q; Wang X; Zhao P; Zuo Y; Qian L; Zhang L; Zheng H
Exp Cell Res; 2017 Jul; 356(1):1-7. PubMed ID: 28506875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
